The following information is current as of 10:00pm on tuesday the 19th of May - It is part of my own due diligence and any inquiries please forward to [email protected] thankyou.
HCT – Holista Colltech Limited – ASX listed
Share Price: 0.16 cents
Market Cap: $41million
Share on issue: 243million
Website: http://www.holistaco.com/index.html
Affiliate website: https://natshieldusa.com/
Technical Chart: This is the current HCT chart showing a base forming with all moving averages lined up and back in an upwards trend - previous high of 34 to be tested soon.
![]()
Holista CollTech Ltd, The scope for growth is in this company is simply incredible – they have multiple revenue streams across several different sectors with all of them being in the commercialization/sales phase of the project after many years of research and development.
Holista Colltech Ltd is a research-driven biotech company and is the result of the merger of Holista Biotech Sdn Bhd and CollTech Australia Ltd. Headquartered in Perth with extensive operations in Malaysia, Holista is dedicated to delivering first-class natural ingredients and wellness products, and leads in research on herbs and food ingredients. Holista, listed on the Australian Stock Exchange (ASX:HCT), researches, develops, manufactures and markets health-style products to address the unmet and growing needs of natural medicine.
1 Year share performance from low (.004) to high (.024) = 500%
![]()
Cash on hand at end of year : $101k – This is extremely rare for a company to have such a low cash balance, but given that a HUGE portion of the top 20 is held
By directors – it shows how important it is to minimize dilution for them and fellow shareholders – less free float means less liquidity when the stock does start
To run, And huge gains can be easily made once the sell side dries up.
Cash now : Circa $4.3million – hard to calculate as they have multiple sales avenues and revenue incoming at increasing frequencies (see pic for cash raise/CPA)
![]()
Announcements: Holista has been extremely busy this year and are very proactive with there plans to bring their product onto the global scene
With huge demand, and with the formation of several recent distribution partnerships I imagine this trend will continue at an accelerating rate.
Rather than Put it into my own words I will insert their latest announcements in chronological order to allow you to see how quickly they are growing, and it shows they have a clearly defined path to success.
Firstly, this Ann from last year announcing they have filed a patent for their CBD absorption technology
![]()
The following was the initial Ann which spiked my interest in HCT
![]()
Shortly after they announced they were developing a nasal balm using their patented path-way solution
![]()
Next, they announced they were entering into a collaboration agreement to develop the nasal balm as well as extending distribution rights for path-away
![]()
Followed by Dr Martin – the creator of path away joining Holista’s advisory board
![]()
3rd of March – Letter signed by Global Infections Control Consultants LLC (the developer of pathaway and natshield) and Holista – giving Holista GLOBAL distribution rights.
![]()
MAIDEN SALES OF $1.4M FOR 80LESS™ SUGAR FORMULATION
![]()
COMMENCEMENT OF TESTS IN U.K. LAB OF PATHAWAY®‘S EFFICACY AGAINST COVID-19 AND OTHER CORONAVIRUSES: -
![]()
HOLISTA APPOINTS EXCLUSIVE U.S. DISTRIBUTOR FOR NATSHIELD ™ SANITISER WITH CONFIRMED
SALES ORDER OF A$3.0 MILLION IN FIRST YEAR – 19th March
![]()
Skin Elements Enters Binding Agreement
with Holista Colltech To Launch All-Natural Skin Friendly Sanitiser within Australia
![]()
HOLISTA’S U.S. DISTRIBUTOR INCREASES ORDERS OF NATSHIELD™ AMOUNTING TO A$3.8M – 9th April, just 3 weeks after signing a $3m a year distribution agreement
That total value of orders necessary for the contract has been eclipsed in just three weeks.…. HUGE.
![]()
CONVERSION OF PERFORMANCE RIGHTS
![]()
HOLISTA ANNOUNCES SUCCESSFUL U.K. LAB TESTS SHOWING NATSHIELD’S ACTIVE INGREDIENT EFFICACY AGAINST THE SURROGATE OF COVID-19
![]()
Clarification of previous announcement-Acceleration of Natshield Global Roll-out After Raising $2.2M - CPA now terminated after raising $6.5M since February 2020
![]()
HOLISTA COLLTECH LIMITED APPENDIX 4C QUARTERLY REPORT
![]()
![]()
![]()
NATSHIELD TO BE TRIALED BY THE INTELLIGENT STERILIZATION ROBOTS IN ASIAN INTERNATIONAL AIRPORT
![]()
HOLISTA FILES GLOBAL PATENT FOR NATSHIELD NASAL SANITIZING BALM
![]()
APPOINTMENT OF U.K. DISTRIBUTOR FOR NATSHIELD™ SANITISER
![]()
Now that we have covered all the recent announcements, Lets have a quick look at their Natshield product range so far.
![]()
And now let’s look at Holista Colltechs own line of products currently available for purchase
![]()
![]()
![]()
![]()
Now to finish let’s look at the top 20 and management
TOP 20:
![]()
Note: Will analyse at a later date but important thing to note here is the huge amount held by management - This is so massively important in small cap stocks – skin in the game, interests aligned. NB: Dr. Rajen Manicka recently received 8m well earned performance shares after the date of this list. - This list is outdated (from their annual report), from what i have heard Acuity is gone and there is 3 new holders on the list with none of the rest decreasing their holdings.
“The mission of Holista CollTech Ltd is to provide society with all natural health-style products through innovations that advances the eminence of life and meeting customer needs, providing employees with momentous work environment and advancement opportunities, enhancing partner′s business and investors with a greater rate of return.”
- Forums
- ASX - By Stock
- HCT
- HCT - In A Nutshell - KJ
HCT - In A Nutshell - KJ
-
- There are more pages in this discussion • 517 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HCT (ASX) to my watchlist
|
|||||
Last
2.6¢ |
Change
0.001(4.00%) |
Mkt cap ! $7.248M |
Open | High | Low | Value | Volume |
2.6¢ | 2.7¢ | 2.6¢ | $7.846K | 298.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 150716 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.6¢ | 210153 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 150716 | 0.025 |
1 | 145777 | 0.024 |
1 | 143012 | 0.023 |
2 | 261916 | 0.018 |
1 | 216921 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.026 | 210153 | 2 |
0.027 | 29629 | 1 |
0.028 | 700000 | 1 |
0.029 | 128000 | 3 |
0.030 | 100000 | 1 |
Last trade - 11.41am 27/08/2024 (20 minute delay) ? |
Featured News
HCT (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online